The following update was provided to the KPhA Board of Directors by 1861 Consulting on pharmacy-related topics for the board's March 11 meeting:
PBM Licensure, Enhanced Regulation (SB 244 / HB 2383)
SB 244 and HB 2383 would require licensure of pharmacy benefits managers and their enhanced regulation. Neither bill is scheduled for a hearing or exempted from deadlines.
Point of Care Test & Treat (SB 200 / HB 2385)
HB 2385 and SB 200 would allow a pharmacist to test and initiate therapy for a health condition that is generally managed with minimal treatment including, but not limited to: Influenza, streptococcus, COVID-19, pre-exposure prophylaxis, post-exposure prophylaxis, and other CLIA waived tests. On February 25th the Senate Health Committee heard proponent testimony speaking to issues surrounding access to care, breadth of pharmacists education, and how other states have adopted similar provisions. Opponent testimony raised concerns about the need for a physician-led care team, possibility of care fragmentation, and broad nature of the bill language lacking physician involvement. Following the hearing, the Committee Chair recommended conferees work together to come to an agreement.
Reimbursement for Pharmacist Services (HB 2388)
HB 2388 would require insurers that provide coverage of a professional service provided by a physician, APRN, or a PA also provide coverage for such services if lawfully provided by a pharmacist. This bill has not been scheduled for a hearing or exempted from deadlines.
Board of Pharmacy Authority, Telepharmacy (SB 251 / HB 2280)
HB 2280 and SB 251 would amend the Board of Pharmacy's regulatory and investigative authority, allow for telepharmacy in Kansas, and a series of other technical updates. SB 251 is exempted from deadlines while the House approved HB 2280 on a vote of 116-8 on March 3rd.
PMP Updates, Integration Fees (SB 168 / HB 2253)
HB 2253 and SB 168 would provide a series of updates to Kansas’ prescription drug monitoring program (K-TRACS), allow the Board of Pharmacy to adopt regulations necessary to establish a fee for integration into an electronic health record/pharmacy management system, access by delegates/researchers, and allow for a medical care facility to request deidentified program data. Neither bill has been scheduled for a hearing, however both are exempt from deadlines.
State Budget (HB 2396 / HB 2397 / SB 267 / SB 268)
The FY 2022 $20.9B Budget plan currently includes, but is not limited to, maintenance of school funding; reamortization of state employees retirement fund, Medicaid Expansion, a digital product tax, a marketplace facilitator tax, pay raise for state employees, a reduced sweep of transportation funding, and technology improvements for the State. Kansas Legislation requires a 7.5% SGF ending balance. The Governor’s main budget bills are HB 2397 & SB 267 and supplemental budget bills are HB 2396 & SB 268.
Friday, March 5 – Deadline for consideration of bills in House of Origin (Turnaround Day) March 6 through March 9 – No Session Friday, March 26 – Last Day Non-Exempt Committee Consideration Wednesday, March 31 – Deadline for consideration of bills in 2nd House (On floor all day the entire week) April 1 - April 5 – No Session Friday, April 9 – First Adjournment Monday, May 1 – Veto Session Begins
Senator Bob Dole Cancer Diagnosis
Bob Dole, former United States Senator of Kansas and 1996 Republican Presidential nominee, announced that he has been diagnosed with stage 4 lung cancer. He served the public for decades; elected first to the U.S. Congress, Dole began his first term in the Senate in 1969 where he served until 1996. Dole, 96, said in a statement that he will start treatment next week.